Brief: In A Major Win For Vanda, A Federal Appeals Court Overturns FDA's Order Denying Approval Of Hetlioz For The Treatment Of Jet Lag Disorder
Aug 18 (Reuters) - Vanda Pharmaceuticals Inc VNDA.O: IN A MAJOR WIN FOR VANDA, A FEDERAL APPEALS COURT OVERTURNS FDA'S ORDER DENYING APPROVAL OF HETLIOZ FOR THE TREATMENT OF JET LAG DISORDER Source text: ID:nPn5dPy4a Further company coverage: VNDA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vanda Pharmaceuticals
See all newsUS STOCKS ON THE MOVE-Caterpillar, Kimberly-Clark, Bending Spoons
US STOCKS ON THE MOVE-Walmart, Super Micro, FMC
US STOCKS ON THE MOVE-Nvidia, Penske Automotive, ManpowerGroup
US STOCKS ON THE MOVE-Barrick Mining, Venture Global, GE Vernova
Vanda Pharma shares slip as trial failure halts anxiety drug program